{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:50:32Z","timestamp":1789404632010,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05707-0","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:26:32Z","timestamp":1769649992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Roseburia intestinalis Offers Vagus-Dependent Neuroprotection Against Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Mengyun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"s1","key":"5707_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/jpd-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8(s1):S3-s8. https:\/\/doi.org\/10.3233\/jpd-181474","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"5707_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00739-6","volume":"10","author":"GW de Klerk","year":"2024","unstructured":"de Klerk GW, van Laar T, Meles SK (2024) A retrospective study of the MDS criteria for prodromal Parkinson\u2019s disease in the general population. NPJ Parkinsons Dis 10(1):125. https:\/\/doi.org\/10.1038\/s41531-024-00739-6","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"5707_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","volume":"20","author":"F Stocchi","year":"2024","unstructured":"Stocchi F, Bravi D, Emmi A, Antonini A (2024) Parkinson disease therapy: current strategies and future research priorities. Nat Rev Neurol 20(12):695\u2013707. https:\/\/doi.org\/10.1038\/s41582-024-01034-x","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"5707_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"5707_CR5","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S, Aktas B, Pita C, et al. (2024) The immune system in Parkinson\u2019s disease: what we know so far. Brain 147(10):3306\u20133324. https:\/\/doi.org\/10.1093\/brain\/awae177","journal-title":"Brain"},{"issue":"6","key":"5707_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol 106(6):518\u2013526. https:\/\/doi.org\/10.1007\/s00401-003-0766-2","journal-title":"Acta Neuropathol"},{"issue":"1","key":"5707_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Signal Transduct Target Ther"},{"key":"5707_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells12192336","author":"T Wang","year":"2023","unstructured":"Wang T, Sun Y, Dettmer U (2023) Astrocytes in Parkinson\u2019s disease: from role to possible intervention. Cells. https:\/\/doi.org\/10.3390\/cells12192336","journal-title":"Cells"},{"issue":"1","key":"5707_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03462-y","volume":"22","author":"F Lind-Holm Mogensen","year":"2025","unstructured":"Lind-Holm Mogensen F, Seibler P, Gr\u00fcnewald A, Michelucci A (2025) Microglial dynamics and neuroinflammation in prodromal and early Parkinson\u2019s disease. J Neuroinflammation 22(1):136. https:\/\/doi.org\/10.1186\/s12974-025-03462-y","journal-title":"J Neuroinflammation"},{"key":"5707_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol 8:37. https:\/\/doi.org\/10.3389\/fneur.2017.00037","journal-title":"Front Neurol"},{"issue":"1","key":"5707_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00803-1","volume":"10","author":"A Evancho","year":"2024","unstructured":"Evancho A, Do M, Fortenberry D, Billings R, Sartayev A, Tyler WJ (2024) Vagus nerve stimulation in Parkinson\u2019s disease: a scoping review of animal studies and human subjects research. NPJ Parkinsons Dis 10(1):199. https:\/\/doi.org\/10.1038\/s41531-024-00803-1","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"5707_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00724-z","volume":"10","author":"H Nishiwaki","year":"2024","unstructured":"Nishiwaki H, Ueyama J, Ito M, Hamaguchi T, Takimoto K, Maeda T, Kashihara K, Tsuboi Y, et al. (2024) Meta-analysis of shotgun sequencing of gut microbiota in Parkinson\u2019s disease. NPJ Parkinsons Dis 10(1):106. https:\/\/doi.org\/10.1038\/s41531-024-00724-z","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"5707_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00894-4","volume":"11","author":"ME Krueger","year":"2025","unstructured":"Krueger ME, Boles JS, Simon ZD, Alvarez SD, McFarland NR, Okun MS, Zimmermann EM, Forsmark CE, et al. (2025) Comparative analysis of Parkinson\u2019s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion. NPJ Parkinsons Dis 11(1):50. https:\/\/doi.org\/10.1038\/s41531-025-00894-4","journal-title":"NPJ Parkinsons Dis"},{"issue":"9","key":"5707_CR14","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, et al. (2020) Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov Disord 35(9):1626\u20131635. https:\/\/doi.org\/10.1002\/mds.28119","journal-title":"Mov Disord"},{"key":"5707_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.757718","volume":"11","author":"K Nie","year":"2021","unstructured":"Nie K, Ma K, Luo W, Shen Z, Yang Z, Xiao M, Tong T, Yang Y, et al. (2021) Roseburia intestinalis: a beneficial gut organism from the discoveries in genus and species. Front Cell Infect Microbiol 11:757718. https:\/\/doi.org\/10.3389\/fcimb.2021.757718","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"5707_CR16","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","volume":"72","author":"X Kang","year":"2023","unstructured":"Kang X, Liu C, Ding Y, Ni Y, Ji F, Lau HCH, Jiang L, Sung JJ, et al. (2023) Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells. Gut 72(11):2112\u20132122. https:\/\/doi.org\/10.1136\/gutjnl-2023-330291","journal-title":"Gut"},{"key":"5707_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115049","author":"A Bircher","year":"2025","unstructured":"Bircher A, Katkeviciute E, Morsy Y, Lang S, Montalban-Arques A, Scharl M (2025) Roseburia intestinalis modulates immune responses by inducing M1 macrophage polarization. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26115049","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5707_CR18","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/jgh.14144","volume":"33","author":"Z Shen","year":"2018","unstructured":"Shen Z, Zhu C, Quan Y, Yang J, Yuan W, Yang Z, Wu S, Luo W, et al. (2018) Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responses. J Gastroenterol Hepatol 33(10):1751\u20131760. https:\/\/doi.org\/10.1111\/jgh.14144","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"5707_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41564-018-0272-x","volume":"3","author":"K Kasahara","year":"2018","unstructured":"Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, et al. (2018) Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol 3(12):1461\u20131471. https:\/\/doi.org\/10.1038\/s41564-018-0272-x","journal-title":"Nat Microbiol"},{"issue":"9","key":"5707_CR20","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","volume":"63","author":"H Tilg","year":"2014","unstructured":"Tilg H, Moschen AR (2014) Microbiota and diabetes: an evolving relationship. Gut 63(9):1513\u20131521. https:\/\/doi.org\/10.1136\/gutjnl-2014-306928","journal-title":"Gut"},{"issue":"3","key":"5707_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1142\/s0192415x25500314","volume":"53","author":"X Shao","year":"2025","unstructured":"Shao X, Li M, Shi S, Wu T, Zhang Y, Guo S, Lin H, Qi X (2025) Neuroprotective effects of Paeonia lactiflora through the regulation of gut Dubosiella in an MPTP-induced Parkinson\u2019s disease mouse model. Am J Chin Med 53(3):833\u2013862. https:\/\/doi.org\/10.1142\/s0192415x25500314","journal-title":"Am J Chin Med"},{"issue":"1","key":"5707_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45636-x","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tu S, Ji X, Wu J, Meng J, Gao J, Shao X, Shi S, et al. (2024) Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway. Nat Commun 15(1):1333. https:\/\/doi.org\/10.1038\/s41467-024-45636-x","journal-title":"Nat Commun"},{"issue":"6","key":"5707_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bj\u00f6rklund T, Wang ZY, Roybon L, et al. (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128(6):805\u2013820. https:\/\/doi.org\/10.1007\/s00401-014-1343-6","journal-title":"Acta Neuropathol"},{"issue":"4","key":"5707_CR24","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1021\/acs.jafc.1c07711","volume":"70","author":"L Wang","year":"2022","unstructured":"Wang L, Zhao Z, Zhao L, Zhao Y, Yang G, Wang C, Gao L, Niu C, et al. (2022) Lactobacillus plantarum DP189 reduces \u03b1-SYN aggravation in MPTP-induced Parkinson\u2019s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. J Agric Food Chem 70(4):1163\u20131173. https:\/\/doi.org\/10.1021\/acs.jafc.1c07711","journal-title":"J Agric Food Chem"},{"issue":"10","key":"5707_CR25","doi-asserted-by":"publisher","first-page":"7534","DOI":"10.1007\/s12035-024-04038-2","volume":"61","author":"Y Dong","year":"2024","unstructured":"Dong Y, Qi Y, Chen J, Han S, Su W, Ma X, Yu Y, Wang Y (2024) Neuroprotective effects of Bifidobacterium animalis subsp. lactis NJ241 in a mouse model of Parkinson\u2019s disease: implications for gut microbiota and PGC-1\u03b1. Mol Neurobiol 61(10):7534\u20137548. https:\/\/doi.org\/10.1007\/s12035-024-04038-2","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5707_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, W\u00fcllner U (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9(1):39. https:\/\/doi.org\/10.1186\/s13073-017-0428-y","journal-title":"Genome Med"},{"issue":"3","key":"5707_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/jpd-140389","volume":"4","author":"M Trupp","year":"2014","unstructured":"Trupp M, Jonsson P, \u00d6hrfelt A, Zetterberg H, Obudulu O, Malm L, Wuolikainen A, Linder J, et al. (2014) Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson\u2019s disease. J Parkinsons Dis 4(3):549\u2013560. https:\/\/doi.org\/10.3233\/jpd-140389","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"5707_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0304-2","volume":"14","author":"Y Shao","year":"2019","unstructured":"Shao Y, Le W (2019) Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease. Mol Neurodegener 14(1):3. https:\/\/doi.org\/10.1186\/s13024-018-0304-2","journal-title":"Mol Neurodegener"},{"key":"5707_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051474","author":"F Magne","year":"2020","unstructured":"Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R (2020) The Firmicutes\/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients. https:\/\/doi.org\/10.3390\/nu12051474","journal-title":"Nutrients"},{"issue":"6","key":"5707_CR30","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/hypertensionaha.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, Zadeh M, Gong M, et al. (2015) Gut dysbiosis is linked to hypertension. Hypertension 65(6):1331\u20131340. https:\/\/doi.org\/10.1161\/hypertensionaha.115.05315","journal-title":"Hypertension"},{"issue":"1","key":"5707_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A (2021) Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis 7(1):27. https:\/\/doi.org\/10.1038\/s41531-021-00156-z","journal-title":"NPJ Parkinsons Dis"},{"key":"5707_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.875101","volume":"13","author":"X Guo","year":"2022","unstructured":"Guo X, Tang P, Hou C, Chong L, Zhang X, Liu P, Chen L, Liu Y, et al. (2022) Integrated microbiome and host transcriptome profiles link Parkinson\u2019s disease to Blautia genus: evidence from feces, blood, and brain. Front Microbiol 13:875101. https:\/\/doi.org\/10.3389\/fmicb.2022.875101","journal-title":"Front Microbiol"},{"key":"5707_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/nu16162660","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Chen B, Zhang X, Akbar MT, Wu T, Zhang Y, Zhi L, Shen Q (2024) Exploration of the Muribaculaceae family in the gut microbiota: diversity, metabolism, and function. Nutrients. https:\/\/doi.org\/10.3390\/nu16162660","journal-title":"Nutrients"},{"key":"5707_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2015.00084","volume":"5","author":"NO Kaakoush","year":"2015","unstructured":"Kaakoush NO (2015) Insights into the role of Erysipelotrichaceae in the human host. Front Cell Infect Microbiol 5:84. https:\/\/doi.org\/10.3389\/fcimb.2015.00084","journal-title":"Front Cell Infect Microbiol"},{"issue":"22","key":"5707_CR35","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, et al. (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110(22):9066\u20139071. https:\/\/doi.org\/10.1073\/pnas.1219451110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5707_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","volume":"23","author":"H Plovier","year":"2017","unstructured":"Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, et al. (2017) A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 23(1):107\u2013113. https:\/\/doi.org\/10.1038\/nm.4236","journal-title":"Nat Med"},{"key":"5707_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934695","volume":"13","author":"VF Rodrigues","year":"2022","unstructured":"Rodrigues VF, Elias-Oliveira J, Pereira \u00cdS, Pereira JA, Barbosa SC, Machado MSG, Carlos D (2022) Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Front Immunol 13:934695. https:\/\/doi.org\/10.3389\/fimmu.2022.934695","journal-title":"Front Immunol"},{"key":"5707_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14030238","author":"CM Qiao","year":"2024","unstructured":"Qiao CM, Huang WY, Zhou Y, Quan W, Niu GY, Li T, Zhang MX, Wu J, et al. (2024) Akkermansia muciniphila is beneficial to a mouse model of Parkinson\u2019s disease, via alleviated neuroinflammation and promoted neurogenesis, with involvement of SCFAs. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci14030238","journal-title":"Brain Sci"},{"issue":"4","key":"5707_CR39","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1007\/s12602-025-10499-1","volume":"17","author":"W Wang","year":"2025","unstructured":"Wang W, Shi S, Su M, Li Y, Yao X, Jiang J, Yao W, Qin X, et al. (2025) Akkermansia muciniphila Akk11 supplementation attenuates MPTP-induced neurodegeneration by inhibiting microglial NLRP3 inflammasome. Probiotics Antimicrob Proteins 17(4):2348\u20132361. https:\/\/doi.org\/10.1007\/s12602-025-10499-1","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"5707_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06767-y","volume":"7","author":"S Saiki","year":"2017","unstructured":"Saiki S, Hatano T, Fujimaki M, Ishikawa KI, Mori A, Oji Y, Okuzumi A, Fukuhara T, et al. (2017) Decreased long-chain acylcarnitines from insufficient \u03b2-oxidation as potential early diagnostic markers for Parkinson\u2019s disease. Sci Rep 7(1):7328. https:\/\/doi.org\/10.1038\/s41598-017-06767-y","journal-title":"Sci Rep"},{"issue":"10","key":"5707_CR41","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/brain\/awac176","volume":"145","author":"J Galper","year":"2022","unstructured":"Galper J, Dean NJ, Pickford R, Lewis SJG, Halliday GM, Kim WS, Dzamko N (2022) Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease. Brain 145(10):3472\u20133487. https:\/\/doi.org\/10.1093\/brain\/awac176","journal-title":"Brain"},{"key":"5707_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30308","author":"MH Flores-Torres","year":"2025","unstructured":"Flores-Torres MH, Peng X, Jeanfavre S, Clish C, Wang Y, McCullough ML, Healy B, Schwarzschild MA, et al. (2025) Plasma metabolomics profiles in prodromal and clinical Parkinson\u2019s disease. Mov Disord. https:\/\/doi.org\/10.1002\/mds.30308","journal-title":"Mov Disord"},{"issue":"2","key":"5707_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18(2):101\u2013113. https:\/\/doi.org\/10.1038\/nrn.2016.178","journal-title":"Nat Rev Neurosci"},{"key":"5707_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11010051","author":"MR McCann","year":"2021","unstructured":"McCann MR, la George De Rosa MV, Rosania GR, Stringer KA (2021) L-carnitine and acylcarnitines: mitochondrial biomarkers for precision medicine. Metabolites. https:\/\/doi.org\/10.3390\/metabo11010051","journal-title":"Metabolites"},{"issue":"8","key":"5707_CR45","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.8.32","volume":"61","author":"G Liew","year":"2020","unstructured":"Liew G, Tse B, Ho IV, Joachim N, White A, Pickford R, Maltby D, Gopinath B, et al. (2020) Acylcarnitine abnormalities implicate mitochondrial dysfunction in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 61(8):32. https:\/\/doi.org\/10.1167\/iovs.61.8.32","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"5707_CR46","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325\u20132340. https:\/\/doi.org\/10.1194\/jlr.R036012","journal-title":"J Lipid Res"},{"issue":"7","key":"5707_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0276-5","volume":"51","author":"M Xu","year":"2019","unstructured":"Xu M, Jiang Z, Wang C, Li N, Bo L, Zha Y, Bian J, Zhang Y, et al. (2019) Acetate attenuates inflammasome activation through GPR43-mediated Ca2+-dependent NLRP3 ubiquitination. Exp Mol Med 51(7):1\u201313. https:\/\/doi.org\/10.1038\/s12276-019-0276-5","journal-title":"Exp Mol Med"},{"key":"5707_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.580171","volume":"11","author":"JR Moffett","year":"2020","unstructured":"Moffett JR, Puthillathu N, Vengilote R, Jaworski DM, Namboodiri AM (2020) Acetate revisited: a key biomolecule at the nexus of metabolism, epigenetics, and oncogenesis - part 2: acetate and ACSS2 in health and disease. Front Physiol 11:580171. https:\/\/doi.org\/10.3389\/fphys.2020.580171","journal-title":"Front Physiol"},{"key":"5707_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111376","volume":"150","author":"Y Hou","year":"2021","unstructured":"Hou Y, Li X, Liu C, Zhang M, Zhang X, Ge S, Zhao L (2021) Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson\u2019s disease. Exp Gerontol 150:111376. https:\/\/doi.org\/10.1016\/j.exger.2021.111376","journal-title":"Exp Gerontol"},{"key":"5707_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/nu15040930","author":"TT Guo","year":"2023","unstructured":"Guo TT, Zhang Z, Sun Y, Zhu RY, Wang FX, Ma LJ, Jiang L, Liu HD (2023) Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson\u2019s disease. Nutrients. https:\/\/doi.org\/10.3390\/nu15040930","journal-title":"Nutrients"},{"issue":"3","key":"5707_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1194","volume":"12","author":"Y Xu","year":"2024","unstructured":"Xu Y, Wen L, Tang Y, Zhao Z, Xu M, Wang T, Chen Z (2024) Sodium butyrate activates the K(ATP) channels to regulate the mechanism of Parkinson\u2019s disease microglia model inflammation. Immun Inflamm Dis 12(3):e1194. https:\/\/doi.org\/10.1002\/iid3.1194","journal-title":"Immun Inflamm Dis"},{"key":"5707_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1099018","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu S, Qian Y, Mo C, Ai P, Yang X, Xiao Q (2023) Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson\u2019s disease by regulating gut microbiota. Front Aging Neurosci 15:1099018. https:\/\/doi.org\/10.3389\/fnagi.2023.1099018","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"5707_CR53","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/kjm2.12745","volume":"39","author":"LL Ji","year":"2023","unstructured":"Ji LL, Huang TT, Mao LL, Xu YF, Chen WY, Wang WW, Wang LH (2023) The gut microbiota metabolite butyrate mitigates MPTP\/MPP(+) -induced Parkinson\u2019s disease by inhibiting the JAK2\/STAT3 signaling pathway. Kaohsiung J Med Sci 39(10):1002\u20131010. https:\/\/doi.org\/10.1002\/kjm2.12745","journal-title":"Kaohsiung J Med Sci"},{"key":"5707_CR54","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","volume":"91","author":"J Sun","year":"2021","unstructured":"Sun J, Li H, Jin Y, Yu J, Mao S, Su KP, Ling Z, Liu J (2021) Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway. Brain Behav Immun 91:703\u2013715. https:\/\/doi.org\/10.1016\/j.bbi.2020.10.014","journal-title":"Brain Behav Immun"},{"issue":"9","key":"5707_CR55","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s11064-020-03074-3","volume":"45","author":"CM Qiao","year":"2020","unstructured":"Qiao CM, Sun MF, Jia XB, Li Y, Zhang BP, Zhao LP, Shi Y, Zhou ZL, et al. (2020) Sodium butyrate exacerbates Parkinson\u2019s disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model. Neurochem Res 45(9):2128\u20132142. https:\/\/doi.org\/10.1007\/s11064-020-03074-3","journal-title":"Neurochem Res"},{"key":"5707_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1388401","volume":"15","author":"JD Elford","year":"2024","unstructured":"Elford JD, Becht N, Garssen J, Kraneveld AD, Perez-Pardo P (2024) Buty and the beast: the complex role of butyrate in Parkinson\u2019s disease. Front Pharmacol 15:1388401. https:\/\/doi.org\/10.3389\/fphar.2024.1388401","journal-title":"Front Pharmacol"},{"issue":"3","key":"5707_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12263-011-0218-x","volume":"6","author":"V Taverniti","year":"2011","unstructured":"Taverniti V, Guglielmetti S (2011) The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr 6(3):261\u2013274. https:\/\/doi.org\/10.1007\/s12263-011-0218-x","journal-title":"Genes Nutr"},{"issue":"3","key":"5707_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3920\/bm2016.0158","volume":"8","author":"H Sugahara","year":"2017","unstructured":"Sugahara H, Yao R, Odamaki T, Xiao JZ (2017) Differences between live and heat-killed bifidobacteria in the regulation of immune function and the intestinal environment. Benef Microbes 8(3):463\u2013472. https:\/\/doi.org\/10.3920\/bm2016.0158","journal-title":"Benef Microbes"},{"key":"5707_CR59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2024.11.023","volume":"124","author":"L Ma","year":"2025","unstructured":"Ma L, Wang HB, Hashimoto K (2025) The vagus nerve: an old but new player in brain-body communication. Brain Behav Immun 124:28\u201339. https:\/\/doi.org\/10.1016\/j.bbi.2024.11.023","journal-title":"Brain Behav Immun"},{"issue":"6","key":"5707_CR60","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165(6):1332\u20131345. https:\/\/doi.org\/10.1016\/j.cell.2016.05.041","journal-title":"Cell"},{"issue":"1","key":"5707_CR61","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41467-018-05901-2","volume":"9","author":"M Sun","year":"2018","unstructured":"Sun M, Wu W, Chen L, Yang W, Huang X, Ma C, Chen F, Xiao Y, et al. (2018) Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun 9(1):3555. https:\/\/doi.org\/10.1038\/s41467-018-05901-2","journal-title":"Nat Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05707-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:26:33Z","timestamp":1769649993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05707-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5707"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05707-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols were approved by the Animal Care and Use Committee of Shaoxing Peoples\u2019 Hospital (2025Z070).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"403"}}